# Use of Autologous Platelet-Rich Plasma to Treat Hypertrophic Burn Scars

> **NCT03935594** · PHASE2 · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 3 (actual)

## Conditions studied

- Hypertrophic Scar

## Interventions

- **BIOLOGICAL:** PRP Injection
- **DRUG:** Saline Injection

## Key facts

- **NCT ID:** NCT03935594
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-18
- **Primary completion:** 2021-05-24
- **Final completion:** 2022-10-19
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Intervention causing discomfort to participants
- **Last updated:** 2023-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03935594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03935594, "Use of Autologous Platelet-Rich Plasma to Treat Hypertrophic Burn Scars". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03935594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*